I would rather spend on verification than on volume.
The figures are clear enough; the question is what they mean and what they do not.
I can supply the numbers if the specifics change the answer.
What can I legitimately conclude from this figure?
Answering this needs the country, and even then the answer is a pointer to the relevant authority rather than a ruling.
A research-use-only label is a supplier's statement about intended use. It has no status in customs classification and does not create an exemption for the importer.
Some jurisdictions provide a limited personal-importation allowance for medicines, usually bounded by quantity, by a supply period and by a requirement that the substance is for the importer's own use. Others provide none.
Personal-importation allowances for medicines exist in some jurisdictions with quantity and supply-period limits, and are absent in others.
Research-use labelling is a seller's statement, not a legal category for you.
edited 14 Nov 2025 by lane_transit — fixed an arithmetic slip in the third paragraph
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsSpecifically, the relevant distinction is between substances that are scheduled, substances that are prescription-only medicines and substances that are unclassified.
Most agents discussed on this site are prescription-only medicines where they are licensed at all, which places personal importation under medicines regulation rather than under drug-control law in most jurisdictions.
The relevant detail is that if the amount at stake is material, this is a question for a lawyer in your jurisdiction rather than for a forum in any jurisdiction.
National medicines regulators and customs authorities publish their positions directly, and those are the primary sources for any specific question.
If the stakes are material, ask a lawyer where you live rather than a forum anywhere.
Start with the classification of the specific substance where you live, because the answer differs by substance and not only by country.
The authority that matters is the national medicines regulator plus the customs authority, and both usually publish their position in plain language on their own websites.
It helps to be literal here: enforcement posture and legal position are not the same thing. Consignments arriving without incident establish nothing about the underlying rule.
Nothing here is medical advice, and research-use compounds are not approved for human use in any jurisdiction.
Look up your own regulator and customs authority. They publish the answer directly.
"For research use only" is a statement by the seller about intended use, and it binds nobody.
Onward supply — including at cost, including to friends — is treated separately and much more seriously in most regimes than importation for personal use.
Medicines regulation and drug-control law are distinct legal frameworks in most countries, with different scheduling and different penalties.
Personal importation and onward supply are different acts under different rules.
This is the tag where the site is least able to help and most obliged to say so plainly.
Three broad categories cover most cases: controlled or scheduled substances, prescription-only medicines, and unclassified chemicals. The rules, penalties and enforcement posture differ sharply between them.
Research-use-only labelling is a commercial convention originating in laboratory supply and carries no regulatory status for an individual importer.
Onward supply is a materially different legal act and should not be assumed to follow the same rule as personal importation.
Prior successful deliveries tell you about enforcement, not about legality.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.